ZyVersa Therapeutics, Inc.
ZVSA
$0.7899
-$0.0111-1.39%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -92.22% | -47.75% | 59.11% | -46.84% | 161.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.28% | -41.15% | -34.44% | -4.35% | -21.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -80.53% | -42.51% | 2.31% | -47.30% | -8.83% |
|
|
|||||
| Total Current Assets | -80.53% | -42.51% | 2.31% | -47.30% | -8.83% |
| Net Property, Plant & Equipment | -- | -97.42% | -95.28% | -87.21% | 104.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -39.47% | -39.47% | -81.37% | -81.37% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 110.92% | 110.92% | -- |
| Total Assets | -40.87% | -39.13% | -81.17% | -81.34% | 1,300.28% |
|
|
|||||
| Total Accounts Payable | 4.35% | 2.12% | 27.37% | 39.93% | 36.78% |
| Total Accrued Expenses | 5.21% | 2.45% | 30.65% | 56.21% | 38.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -92.00% | -99.13% |
| Total Finance Division Other Current Liabilities | -98.85% | -98.88% | -99.27% | -59.58% | -70.30% |
| Total Other Current Liabilities | -98.85% | -98.88% | -99.27% | -59.58% | -70.30% |
| Total Current Liabilities | -1.41% | -4.67% | 11.71% | 24.51% | -17.25% |
|
|
|||||
| Total Current Liabilities | -1.41% | -4.67% | 11.71% | 24.51% | -17.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.69% | -40.71% | -90.89% | -92.07% | 334.95% |
| Total Liabilities | -5.72% | -9.03% | -41.60% | -41.41% | -9.19% |
|
|
|||||
| Common Stock & APIC | 7.90% | 9.71% | 11.10% | 9.29% | 118.27% |
| Retained Earnings | -23.73% | -25.10% | -1,152.74% | -1,997.44% | -44.17% |
| Treasury Stock & Other | 0.00% | 0.00% | -- | -- | -- |
| Total Common Equity | -64.34% | -57.03% | -88.44% | -88.89% | 262.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -64.34% | -57.03% | -88.44% | -88.89% | 262.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -64.34% | -57.03% | -88.44% | -88.89% | 262.39% |
|
|
|||||
